European Commission
-
Alvotech’s AVT06 nears European approval for Eylea biosimilar market
The approval of AVT06 follows a growing trend of biosimilars entering the market after Bayer’s patent expiry.
-
-
-
-
European Commission takes action to prevent antibiotic shortages, while US grapples with penicillin supply strains
BELGIUM —The European Commission is proactively addressing potential shortages of key antibiotics by collaborating with manufacturers and healthcare providers, aiming to prevent supply shortfalls during…
-
Illumina slapped with record-breaking US$476 million fine by EU over Grail acquisition
USA — Illumina, the prominent US-based DNA-sequencing company, faces a staggering fine of €432 million (US$476 million) imposed by the European Union for its premature…
-
European Commission signs contract with four vaccine producers to secure manufacturing capacity for future outbreaks
BELGIUM —In a proactive move to prepare for future disease outbreaks, the European Commission has entered into a contract with a group of four vaccine…
-
European regulators approve first vaccine for Respiratory Syncytial Virus (RSV)
UNITED KINGDOM —European regulators have granted approval for the first vaccine targeting respiratory syncytial virus (RSV) in the region. Developed by British pharmaceutical company GSK,…
-
EU Commission’s global health strategy to expand its role worldwide
BELGIUM — The European Commission wants EU member states to play the same decisive role they had in the global response to the COVID-19 pandemic…
-
European Commission approves Sanofi & Astra’s drug for preventing RSV in infants
BELGIUM — The European Commission (EC) has granted approval for AstraZeneca and Sanofi’s Beyfortus (nirsevimab) to prevent respiratory syncytial virus (RSV) lower respiratory tract disease…